Mikawa, K <br/><br/>
ONO-1714, a new inducible nitric oxide synthase inhibitor, attenuates diaphragmatic dysfunction associated with cerulein-induced pancreatitis in rats.  [electronic resource] 

 -  Critical care medicine  Jun 2001 
 - 1215-21 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0090-3493 
<br/><br/><label>Standard No.: </label>10.1097/00003246-200106000-00027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amidines--pharmacology<br/>Analysis of Variance<br/>Animals<br/>Ceruletide<br/>Diaphragm--metabolism<br/>Disease Models, Animal<br/>Enzyme Inhibitors--pharmacology<br/>Heterocyclic Compounds, 2-Ring--pharmacology<br/>Immunohistochemistry<br/>Lipid Peroxidation<br/>Male<br/>Malondialdehyde--metabolism<br/>Muscle Contraction--physiology<br/>Nitric Oxide--blood<br/>Pancreatitis--drug therapy<br/>Prospective Studies<br/>Rats<br/>Rats, Sprague-Dawley<br/>Respiration Disorders--drug therapy<br/>Statistics, Nonparametric